Abstract:Significance Insulin is a target of CD4 T cells in type 1 diabetes in mice and humans. Why the major epitope in the insulin B chain is presented poorly to the diabetogenic CD4 T cells by the disease-associated major histocompatibility class II (MHCII) alleles has been highly debated. Here we present high-resolution mouse and human MHCII structures and T-cell functional data to show that C-terminal modifications of this epitope are required for binding and presentation in the appropriate position in the MHCII binding groove. These results suggest that pancreas-specific posttranslational modifications of this peptide may play a role in the induction of diabetes and explain how the pathogenic T cells escape deletion in the thymus. A polymorphism at β57 in some major histocompatibility complex class II (MHCII) alleles of rodents and humans is associated with a high risk for developing type 1 diabetes (T1D). However, a highly diabetogenic insulin B chain epitope within the B:9–23 peptide is presented poorly by these alleles to a variety of mouse and human CD4 T cells isolated from either nonobese diabetic (NOD) mice or humans with T1D. We have shown for both species that mutations at the C-terminal end of this epitope dramatically improve presentation to these T cells. Here we present the crystal structures of these mutated peptides bound to mouse IAg7 and human HLA-DQ8 that show how the mutations function to improve T-cell activation. In both peptide binding grooves, the mutation of B:22R to E in the peptide changes a highly unfavorable side chain for the p9 pocket to an optimal one that is dependent on the β57 polymorphism, accounting for why these peptides bind much better to these MHCIIs. Furthermore, a second mutation of the adjacent B:21 (E to G) removes a side chain from the surface of the complex that is highly unfavorable for a subset of NOD mouse CD4 cells, thereby greatly enhancing their response to the complex. These results point out the similarities between the mouse and human responses to this B chain epitope in T1D and suggest there may be common posttranslational modifications at the C terminus of the peptide in vivo to create the pathogenic epitopes in both species.

Linkage of Faulty Major Histocompatibility Complex Class I to Autoimmune Diabetes.

Molecular Mechanisms in Autoimmune Type 1 Diabetes: a Critical Review

Autoimmune interactions between the HLA-DQβ157 polymorphism, T cell receptors, and microbial mimics of insulin in type 1 diabetes

Discordant association of islet autoantibodies with high-risk HLA genes in Chinese type 1 diabetes.

Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus

Differences in F pocket impact on HLA I genetic associations with autoimmune diabetes

C-terminal Modification of the Insulin B:11–23 Peptide Creates Superagonists in Mouse and Human Type 1 Diabetes

Structural and biochemical analysis of highly similar HLA-B allotypes differentially associated with type 1 diabetes

HLA-E-restricted Regulatory CD8(+) T Cells Are Involved in Development and Control of Human Autoimmune Type 1 Diabetes.

Type 1 diabetes depends on CD4-driven expression of the transcriptional repressor, Bcl6

CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes

B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice

Exclusive Expression of MHC Class II Proteins on CD45+ Cells in Pancreatic Islets of NOD Mice

Islet amyloid disrupts MHC Class II antigen presentation and protects NOD mice from autoimmune diabetes.

On the Pathogenesis of Insulin-Dependent Diabetes Mellitus — A Discussion of Three Recently Proposed Models

Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive

Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes

Tests for Genetic Interactions in Type 1 Diabetes

CD4+ T cells from individuals with type 1 diabetes respond to a novel class of deamidated peptides formed in pancreatic islets

The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes

Pancreatic ductal cell antigens are important in the development of invasive insulitis in Non-Obese Diabetic mice